Teleflex is a leading medical technology company, offering a diverse portfolio of products and services for critical care and surgical applications. The company's offerings include specialty medical devices, anesthesia and respiratory equipment, and vascular access solutions. Teleflex has a global presence, serving healthcare providers and patients in over 140 countries.
Teleflex's removal from the S&P 500 in 2025 can be attributed to a combination of factors. Firstly, the company faced financial challenges, with declining revenue and earnings in the preceding years, which led to a decrease in market valuation. This was further exacerbated by increased competition from rival medical device manufacturers and a struggle to introduce innovative products to the market. Additionally, a leadership transition within Teleflex may have contributed to its underperformance during this period.